Quote
—
—
We have scored 43 news catalysts on ILMN (ILMN) over the past 12 months. Coverage across the window leans positive (average ticker sentiment +0.44). Most of the impact sits in sector healthcare and price momentum.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
No scored news tagged ILMN or its network in the window yet.
Show more ILMN articles →Analysts publish price targets on ILMN, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
13 analyst price targets from $155 to $235
as of 2026-09-05
The market is 9% above the median target — more optimistic than the analysts.
The reconstruction
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about ILMN — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of ILMN, taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for ILMN: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The price sits 9% above the median published target and at the 77th percentile, paying for an acceleration in growth that the company has not yet delivered.
What the disagreement turns on
Whether the Sequencing segment can actually return to double-digit growth; unit volumes are measurable, but pricing power cannot be tested with the available data.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
